MITA Announces New Regulatory and Standards Director

Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today announced that Megan Hayes has joined the organization as Regulatory and Standards Director.

“MITA is committed to improving patient safety and increasing efficiencies in the delivery of care through medical imaging standards,” said Gail Rodriguez, executive director of MITA. “Megan’s extensive experience with standards strategy and implementation will be a tremendous asset to MITA as we work with our imaging community partners to build upon an already robust set of safety standards.”

In her new role, Hayes will be leading MITA’s efforts to identify opportunities for performance, quality and safety standards, while also promoting current standards among a variety of stakeholders, including regulators, industry and standards development organizations. She will also be working with international regulatory bodies, such as the International Medical Device Regulators Forum (IMDRF), to promote adoption of imaging standards.

“I am pleased to be joining an organization that plays such an integral role in the development and integration of regulations and standards, and look forward to working with MITA and our industry partners on future efforts to enhance patient safety and optimize medical device performance,” said Hayes.

Prior to joining MITA, Hayes developed technical standards at the National Electrical Manufacturers Association (NEMA), MITA’s parent organization. She also led technical standards development for the Alliance for Telecommunications Industry Solutions and the Consumer Electronics Association.

Megan earned her Bachelor’s Degree in Political Science from American University.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.